While I believe Pfizer will rebound eventually, it will take some time to do so, and it may not occur in 2026. In the meantime, other healthcare leaders could perform significantly better this year ...

A controversial housing scheme that would change the face of Hyde ’s green space forever is due to be scrutinised again. The ...

Novo Nordisk faces GLP-1 headwinds after the FDA-approved Wegovy pill, and LLY gains share, margins erode, and the pipeline ...

It's understood the writing was on the wall for the EU-Mercosur agreement not long after the meeting of EU ambassadors got ...

If you want to generate $300 in super-safe dividend income in 2026, simply invest $2,670, split equally three ways, in the ...

Madrigal Pharmaceuticals (MDGL) stock is in focus as the company licenses Pfizer’s (PFE) experimental MASH therapy ervogastat. Read more here.

We recently compiled a list of 9 Most Undervalued Pharma Stocks to Buy Right Now. Pfizer Inc tops our list for being one of the most undervalued pharmaceutical stocks. On Friday, December 12, 2025, ...

In the latest trading session, Pfizer (PFE) closed at $24.88, marking a -1.31% move from the previous day. The stock trailed the S&P 500, which registered a daily gain of 0.46%. At the same time, the ...

Five sensational income stocks -- sporting yields ranging from 5.3% to 13.1% -- can fatten investors' pocketbooks in the new ...

How $2,670 split across three durable high-yield stocks can generate $300 in annual dividends without risky payouts.

A few days earlier, on December 11, Edison International (NYSE:EIX) declared a quarterly common stock dividend of $0.8775 per ...